Your browser doesn't support javascript.
loading
Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy.
Lagerlöf, Ingemar; Fohlin, Helena; Enblad, Gunilla; Glimelius, Bengt; Goldkuhl, Christina; Palma, Marzia; Åkesson, Lisa; Glimelius, Ingrid; Molin, Daniel.
Afiliação
  • Lagerlöf I; Experimental and Clinical Oncology, Department of Immunology, Genetics and Pathology; Uppsala University, Uppsala, Sweden.
  • Fohlin H; Regional Cancer Center of Southeast Sweden and Department of Biomedical and Clinical Sciences, Medical Faculty, Linköping University, Linköping, Sweden.
  • Enblad G; Experimental and Clinical Oncology, Department of Immunology, Genetics and Pathology; Uppsala University, Uppsala, Sweden.
  • Glimelius B; Experimental and Clinical Oncology, Department of Immunology, Genetics and Pathology; Uppsala University, Uppsala, Sweden.
  • Goldkuhl C; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Palma M; Department of Haematology, Karolinska University Hospital, Stockholm, Sweden.
  • Åkesson L; Regional Cancer Center of Southeast Sweden and Department of Biomedical and Clinical Sciences, Medical Faculty, Linköping University, Linköping, Sweden.
  • Glimelius I; Experimental and Clinical Oncology, Department of Immunology, Genetics and Pathology; Uppsala University, Uppsala, Sweden.
  • Molin D; Experimental and Clinical Oncology, Department of Immunology, Genetics and Pathology; Uppsala University, Uppsala, Sweden.
J Clin Oncol ; 40(13): 1487-1496, 2022 05 01.
Article em En | MEDLINE | ID: mdl-35077204

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Doença de Hodgkin / Tromboembolia Venosa Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Doença de Hodgkin / Tromboembolia Venosa Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article